Osteoarthritis Resource Center

Researchers Identify Risk Factors for Radiographic Progression of Osteoarthritis of the Knee

Researchers Identify Risk Factors for Radiographic Progression of Osteoarthritis of the Knee

Patients with mild radiographic osteoarthritis (OA) of the knee who use non-steroidal anti-inflammatory drugs (NSAIDs) and do not meet physical activity guidelines are at...
video

Dr. Mike Clayman, CEO of Flexion Therapeutics, on Developing New Therapies for Musculoskeletal Disorders

DocWire News with spoke with Mike Clayman, M.D., CEO at Flexion Therapeutics, a company focused on the development of novel, local therapies for the...
Could Patients’ Expectations Impact Clinical Response to DMARDs in Rheumatoid Arthritis?

Could Patients’ Expectations Impact Clinical Response to DMARDs in Rheumatoid Arthritis?

A study observed a correlation between patients’ expectations toward newly induced disease-modifying antirheumatic drug (DMARD) therapies and clinical response among patients with rheumatoid arthritis...
nsaid, dr., flu, FDA, Arthritis Medication Comparison, Expert Interviews: Rheum Round-up, PROs, Rheum Round-up: Abatacept vs. Other bDMARDs in RA, OA and Discrimination, and more

Rheum Round-up: Interviews—Dr. Woody on Unmet Needs in Pain and Inflammation, Dr. Hernandez on...

DocWire News recently spoke with Dr. Jim Woody, CEO of 180 Life Sciences, a company that develops new treatments for inflammation. Dr. Woody and his team...
opioid, mdma, opioids

Opioid Use May Be Tied to Knee Degeneration in Osteoarthritis

Opioid users with osteoarthritis of the knee (KOA) had poorer baseline knee structural degeneration and faster progression, according to a study. The results were...
therapies, tocilizumab, rheum, RA, keenan, autoimmune, tofacitinib, telemedicine, covid-19, Hydroxychloroquine, Secukinumab, interview, rheumatologists, rheumatologist, arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: Tocilizumab and Diverticulitis Risk, Pulmonary Arterial Hypertension With Connective Tissue Disease, and...

Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to rituximab and abatacept in patients with rheumatoid arthritis (RA)...
oral, surgeon, treatments, Rheum Round-up: Skyrizi Receives Conditional Approval, Tea and Fracture, PKR vs. TKR, and More

Rheum Round-up: Oral Microbiome Different in RA, Biologics Comparison, and more

A recent study observed differences in oral microbiome between patients with early rheumatoid arthritis (RA) or at high-risk of the disease compared to controls....

Curated Journal Reading List